Literature DB >> 21178819

Patients with Rett syndrome sustain low-energy fractures.

Gitte Roende1, Kirstine Ravn, Kathrine Fuglsang, Henrik Andersen, Aage Vestergaard, Karen Brøndum-Nielsen, Jens-Erik Beck Jensen, Jytte Bieber Nielsen.   

Abstract

We present the first case-control study addressing both fracture occurrence and fracture mechanisms in Rett syndrome (RTT). Two previous studies have shown increased fracture risk in RTT. This was also our hypothesis regarding the Danish RTT population. Therefore, we investigated risk factors associated with low-energy trauma and the association to methyl-CpG-binding protein 2 (MECP2) mutations. A total of 61 female patients with RTT and 122 healthy controls matched according to age and pubertal/menopause status were examined by questionnaires, bone biochemical markers in blood, and clinical and x-ray evaluations. National register search on fracture diagnoses was done to obtain complete fracture histories. Our results showed that patients with RTT sustained significantly more low-energy fractures from early age compared with controls, even though overall fracture occurrence apparently was not increased. Low-energy fractures were significantly associated with less mobility and lack of ambulation. Associations with MECP2 mutations or epilepsy were not demonstrated, contrary to previous findings. Blood biochemistry indicated a possible need for D vitamin supplementation in RTT. Our study casts light on fracture occurrence in RTT and points to a need for future research in bone development and fracture risk to establish directions for improved prevention and treatment of low-energy fractures in RTT.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21178819     DOI: 10.1203/PDR.0b013e31820bc6d3

Source DB:  PubMed          Journal:  Pediatr Res        ISSN: 0031-3998            Impact factor:   3.756


  9 in total

Review 1.  Evaluation of current pharmacological treatment options in the management of Rett syndrome: from the present to future therapeutic alternatives.

Authors:  Christopher A Chapleau; Jane Lane; Lucas Pozzo-Miller; Alan K Percy
Journal:  Curr Clin Pharmacol       Date:  2013-11

Review 2.  Clinical and biological progress over 50 years in Rett syndrome.

Authors:  Helen Leonard; Stuart Cobb; Jenny Downs
Journal:  Nat Rev Neurol       Date:  2016-12-09       Impact factor: 42.937

3.  Gastrointestinal and nutritional problems occur frequently throughout life in girls and women with Rett syndrome.

Authors:  Kathleen J Motil; Erwin Caeg; Judy O Barrish; Suzanne Geerts; Jane B Lane; Alan K Percy; Fran Annese; Lauren McNair; Steven A Skinner; Hye-Seung Lee; Jeffrey L Neul; Daniel G Glaze
Journal:  J Pediatr Gastroenterol Nutr       Date:  2012-09       Impact factor: 2.839

4.  Teriparatide in the treatment of recurrent fractures in a Rett patient.

Authors:  Carla Caffarelli; Jussef Hayek; Ranuccio Nuti; Stefano Gonnelli
Journal:  Clin Cases Miner Bone Metab       Date:  2015-12-29

5.  A qualitative investigation of recovery after femoral fracture in Rett syndrome.

Authors:  T Horne; H Leonard; K Stannage; J Downs
Journal:  Child Care Health Dev       Date:  2016-08-11       Impact factor: 2.508

6.  Biomechanical properties of bone in a mouse model of Rett syndrome.

Authors:  Bushra Kamal; David Russell; Anthony Payne; Diogo Constante; K Elizabeth Tanner; Hanna Isaksson; Neashan Mathavan; Stuart R Cobb
Journal:  Bone       Date:  2014-10-24       Impact factor: 4.398

7.  Methyl-CpG-binding protein 2 (MECP2) mutation type is associated with bone disease severity in Rett syndrome.

Authors:  Carla Caffarelli; Stefano Gonnelli; Maria Dea Tomai Pitinca; Silvia Camarri; Antonella Al Refaie; Joussef Hayek; Ranuccio Nuti
Journal:  BMC Med Genet       Date:  2020-01-31       Impact factor: 2.103

8.  Clinical Guidelines for Management of Bone Health in Rett Syndrome Based on Expert Consensus and Available Evidence.

Authors:  Amanda Jefferson; Helen Leonard; Aris Siafarikas; Helen Woodhead; Sue Fyfe; Leanne M Ward; Craig Munns; Kathleen Motil; Daniel Tarquinio; Jay R Shapiro; Torkel Brismar; Bruria Ben-Zeev; Anne-Marie Bisgaard; Giangennaro Coppola; Carolyn Ellaway; Michael Freilinger; Suzanne Geerts; Peter Humphreys; Mary Jones; Jane Lane; Gunilla Larsson; Meir Lotan; Alan Percy; Mercedes Pineda; Steven Skinner; Birgit Syhler; Sue Thompson; Batia Weiss; Ingegerd Witt Engerström; Jenny Downs
Journal:  PLoS One       Date:  2016-02-05       Impact factor: 3.240

9.  Lower incidence of fracture after IV bisphosphonates in girls with Rett syndrome and severe bone fragility.

Authors:  Anne-Sophie Lambert; Anya Rothenbuhler; Perrine Charles; Sylvie Brailly-Tabard; Séverine Trabado; Elisabeth Célestin; Emmanuel Durand; Isabelle Fontaine; Lotfi Miladi; Philippe Wicart; Nadia Bahi-Buisson; Agnès Linglart
Journal:  PLoS One       Date:  2017-10-26       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.